Mohammad Newaz
Mohammad Newaz MD, Ph.D

Mohammad Newaz MD, Ph.D., FAHA is a Professor of Physiology and Pharmacology and Chair of the Department of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). Before joining CSU Dr. Newaz was Associate Professor / senior Scientist and Head of Hypertension Unit in the Center for Cardiovascular Diseases, Texas Southern University, Houston, Texas. Dr. Newaz received his MD from the University of Chittagong, Bangladesh (1992) and PhD from the National University of Malaysia (1998). He has held faculty positions at the University of Science and Technology Chittagong, Bangladesh, National University of Malaysia and International Islamic University Malaysia before joining the Center for Cardiovascular Diseases in 2000. His research focus is primarily on hypertension and vascular physiology using integrated investigative approach with special emphasis on understanding molecular events contributing to the pathogenesis of hypertension and its complications

Dr. Newaz is a member of many professional societies, including the American Heart Association, American Physiological Society. He has received numerous honors and awards, including the Young Investigator Award from High Blood Pressure Council of American Heart Association, Young Investigator Award from the renal section of The American Physiological Society, Caroline Tun Suden professional opportunity award from The American Physiological Society, Young Investigator Award from The International Society of Hypertension, FASEB MARC fellowship and Grant-in-Aid from American Heart Association. He has published more than 40 peer reviewed research paper in high impact journals, book chapters and invited reviews in the field of hypertension and vascular biology. Dr. Newaz presented his research works extensively at conferences locally and internationally and was also an invited speaker in several Universities in the US. 

Michael Danquah
Michael Danquah, M.S., Ph.D.

Michael Danquah, M.S., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He obtained his Bachelors in Chemical Engineering from Kwame Nkrumah University of Science and Technology, Ghana. Dr. Danquah has a Master’s Degree in Chemical Engineering from the University of Kentucky, and a Ph.D. in Pharmaceutics and Drug Delivery from the University of Tennessee Health Science Center.

Dr. Danquah’s research interests include:  (i) Design and synthesis of novel biodegradable polymers for controlled drug and nucleic acid delivery, (ii) Nano based combination therapy for treating cancer, (iii) Design and construction of novel bipartite shRNA expressing plasmids for cancer therapy, (iv) Formulation, delivery, in vitro and in vivo characterization of siRNA and shRNA for treating cancer and (v) Application of stem cells and biomaterials for tissue regeneration and repair. His research accomplishments in these areas are documented in published peer-reviewed journal articles. Dr. Danquah also serves as a regular reviewer for Pharmaceutical Research and Advanced Drug Delivery Reviews and is a member of the American Association of Colleges of Pharmacy (AACP), the American Association of Pharmaceutical Scientists (AAPS), and the Controlled Release Society (CRS).

Jianjun Chen
Jianjun Chen, B. Pharm., M.S., Ph.D.

Jianjun Chen, B. Pharm., M.S., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He obtained his B. Pharm from Shenyang Pharmaceutical University in China. Dr. Chen has a Master’s degree in Pharmaceutical Chemistry from Kangwon National University College of Pharmacy in S. Korea and a Ph.D. in Pharmaceutical Sciences from the University of Tennessee Health Science Center (UTHSC), College of Pharmacy. Prior to joining CSU-COP, he was an assistant professor of pharmaceutical sciences in South College School of Pharmacy. 

Dr. Chen's research interests include: 1) drug discovery/medicinal chemistry: synthesis and biological testing of novel small molecules for the treatment of cancer; 2) bio-analytical chemistry: drug metabolism and structure elucidation of small molecules using high-resolution NMR and mass spectrometry. Over the years, he has published more than 40 peer-reviewed papers in high impact journals in his field and is a regular reviewer for several professional and scientific journals. Dr. Chen is a co-inventor of multiple U.S. and world patents. He has presented his research work at numerous national and international conferences and meetings such as AAPS, ACS, and AACR. Dr. Chen has also received awards in recognition of his research.


Nadeem Fazal
Nadeem Fazal, M.D, Ph.D. 

Nadeem Fazal, M.D, Ph.D. is a Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He received his MD from King Edward Medical University, Lahore, Pakistan, and PhD in Immunology from The University of Birmingham, England, United Kingdom.  He is a member of American Association for Immunologists (AAI) and American Society for Microbiology (ASM). He completed his Post-doctoral training, Fellowship and later served as faculty at Stritch School of Medicine Loyola University Chicago. Dr. Fazal began his teaching career at the Department of Microbiology and Immunology, Rawalpindi Medical College, The University of Punjab, Lahore. He also served as faculty at Chicago State University Department of Biological Sciences.  He has received President’s and Young Scientist Award from Societies of General Microbiology (SGM), American Society for Microbiology (ASM) and British Society for Immunology (BSI). He was also a recipient of Rowtham Bequest Award from The University of Birmingham, England, United Kingdom. His research interests include investigating mechanisms of cellular immune responses to acute injury/infection and pharmacological agents modulating such host responses. He has published more than 30 papers in peer-reviewed scientific journals. Dr. Fazal is a member of numerous scientific and professional organizations, including, The American Physiological Society (APS), The American Society of Human Genetics (ASHG), and The American Association of Colleges of Pharmacy (AACP). 

Elmer J. Gentry
Elmer J. Gentry, Ph.D

Elmer J. Gentry, Ph.D., is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP).  Dr. Gentry received his B.S. from Missouri Western State College (1993 in Chemistry) and M.S. (1996) and Ph.D. (1999) in Medicinal Chemistry from the University of Kansas.  He served on the faculty at Midwestern University, College of Pharmacy-Glendale from 1999-2007.

He was named the 2007 Teacher of the Year for both the first and second-year pharmacy classes at the College of Pharmacy-Glendale.  Additionally, he has received the Edgar C. Little Outstanding Chemistry Graduate Award from Missouri Western State College, the Pharmacy Graduate Student Honors Symposium Award from the University of Kansas, and an American Foundation for Pharmaceutical Education Pre-doctoral fellowship from 1997-1999.  He was honored as the National Advisor of the Year runner-up by the Phi Delta Chi pharmacy fraternity.

Dr. Gentry is a member of numerous scientific and professional organizations and has served as the Chair of the Section of Teachers of Chemistry of the American Association of Colleges of Pharmacy.  His research interests include:  synthetic manipulation of antimicrobial agents to modulate potency and spectrum of activity, use of combinatorial chemistry for drug discovery and development, and improving delivery of science courses for professional and pre-professional students.

Melany P. Puglisi
Melany P. Puglisi, Ph.D.

Melany P. Puglisi, Ph.D. is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP).  She received her B.A. in chemistry from Southampton College, now part of Long Island University, in 1991.  Her graduate studies were carried out at the University of Guam where she received her M.S. in Biology in 1995 and the University of Mississippi, School of Pharmacy where she received her Ph.D. in pharmacognosy.  She received grants from the American Museum of Natural History and the Australian Museum of Natural History to conduct her research on Guam and the Great Barrier Reef (Lizard Island).

Prior to joining CSU, she conducted post-doctoral research at Scripps Institution of Oceanography at the University of California at San Diego, the Smithsonian Marine Station at Fort Pierce, and Shannon Point Marine Station at Western Washington University.  Dr. Puglisi’s research interests include marine natural products and chemical ecology of algae and marine invertebrates.  She has participated in numerous research expeditions in the tropical Atlantic and Pacific including the 2005 NOAA Florida Coast Deep Corals research cruise. 

Dr. Puglisi is a member of several scientific and professional organizations including the American Association of Colleges of Pharmacy (AACP) and the American Society of Pharmacognosy.  She has served as chair of the Younger Members Committee of the ASP.  Dr. Puglisi has received awards throughout her academic career that not only recognize her research achievements but also highlight her service to the community.

Mohammad Tauseef
Mohammad Tauseef,
M. Pharm., Ph.D.

Mohammad Tauseef, M. Pharm., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He completed his Pharmacy School from Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi, India; and Ph.D., in Cardiovascular Pharmacology from Department of Pharmacology, Faculty of Medical Sciences, University of Delhi, India. Later, he joined Department of Pharmacology,

College of Medicine, The University of Illinois, Chicago, U.S., as a postdoctoral research associate. After completing his postdoctoral training in cardiopulmonary pharmacology, he was appointed as a Research Assistant Professor in Department of Pharmacology, The University of Illinois, Chicago, IL.

Dr. Tauseef performs his biomedical research to investigate the role of calcium signaling in the regulation of vascular endothelial hyper-permeability and inflammation. Increase in endothelial permeability is the earliest sign in the initiation of serious cardiopulmonary disorders during septic conditions, acute respiratory distress syndrome (ARDS) and diabetes mellitus. Dr. Tauseef is trying to identify molecular signaling mechanisms, activated during endothelial dysfunction to develop potential therapeutics against vascular inflammatory diseases. He utilizes array of techniques such as gene silencing technology in endothelial cells and genetic knockout mice models to answer his research questions. He regularly presents his research findings in various national and international scientific meetings such as Federations of America Society of Experimental Biology (FASEB), American Thoracic Society (ATS), American Heart Association (AHA), etc. He is recipient of several awards for his research presentations including Research Recognition Award from American Physiological Society (APS), Young Investigator Award by American Society for Pharmacology and Experimental Therapeutics (ASPET) and Gold Medal Prize, College of
Medicine (COM) Research, University of Illinois Chicago. He is an active member of American Association of College of Pharmacy (AACP), American Association of Immunologists (AAI), American Association of Pharmacology and Experimental Therapeutics. He is a member, Editorial Board, The Journal of Clinical Research. Dr. Tauseef has published his research work in top tier, peer reviewed international journals, such as Circulation Research, Journal of Experimental Medicine, The FASEB Journal. Dr. Tauseef is also an Adjunct Research Assistant Professor at the Center for and Vascular Biology, Department of Pharmacology, College of Medicine, The University of Illinois of Chicago, IL.

Hafeez Faridi
Hafeez Faridi, Ph.D.

Hafeez Faridi, Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He earned his M.Phil and Ph.D. degrees in life sciences from Jawaharlal Nehru University in Delhi, India. Prior to joining CSU, he served as an assistant professor at the department of internal medicine, Rush University Medical Center, Chicago IL. Dr. Faridi completed his postdoctoral training from The University of Miami, Miller School of Medicine, Miami. FL. His postdoctoral work focused on discovery of novel small molecules targeting integrin CD11b. His research led to the discovery of novel integrin CD11b targeting small molecules with anti-inflammatory properties. He has presented his findings in various international meetings.

His research interests are (1) Screening and characterization of small molecules with anti-inflammatory properties. (2) Understanding the physiological mechanisms in chronic kidney disease and identifying the therapeutic targets. Dr. Faridi has published his research work in well known, peer reviewed journals, such as Science Signaling, and Journal of Clinical Investigation (JCI). He is involved in multidisciplinary and collaborative research in the area of drug discovery including inflammation,cancer and chronic kidney diseases.

Dr. Faridi is a member of several scientific and professional organizations, including the American Association of Colleges of Pharmacy (AACP) and the American society of Nephrology (ASN). Dr. Faridialso serves as an active member on various institutional committees including curriculum committee and self-study committee. Dr. Faridi is also an Adjunct Assistant Professor in the Department of Internal Medicine, College of Medicine, Rush University Medical Center. Chicago, IL.


Bathsheba Ellis is an Administrative Aide in the Department of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP).  She has worked at CSU for 17 years in the College of Business. She has two sons and three beautiful grandchildren whom she adores spending time with.  She also loves traveling, fine dining, and going to the theater.  Her greatest joy comes from spending time at church, where she is active as a volunteer.

Daniel W. Pietryla
Daniel W. Pietryla

Daniel W. Pietryla is the Research Laboratory Technician Specialist for Chicago State University College of Pharmacy (CSU-COP). Mr. Pietryla received his Bachelors Degree in Biology from The University of Chicago (1983). Mr. Pietryla is the Lab Manager for the Pharmaceutical Sciences Research Facility.
Before joining the College of Pharmacy at CSU in 2012, Mr. Pietryla was a Research Assistant in the Departments of Biochemistry and Orthopedics at Rush University Medical Center in Chicago. In a career in basic research spanning 27 years, Mr. Pietryla has contributed to, as Co-Author, 6 major publications and 29 scientific abstracts on topics ranging from joint inflammation to intervertebral disc degradation and repair. Mr. Pietryla brings diverse technical skills in biochemical, histological, immunological, surgical, and clinical protocols and methodologies to the Pharmaceutical Sciences Research Lab. Additional information at